MNTNHIGH SIGNALOPPORTUNITY10-Q

MNTN delivered exceptional financial performance with revenue growing 52.7% to $203M and a remarkable turnaround from -$4.0M operating loss to $3.5M operating profit.

This represents a significant inflection point for MNTN, demonstrating the company has achieved operational leverage and scale in its business model. The substantial revenue growth combined with positive operating income suggests the company's strategic investments are paying off and management has successfully navigated toward profitability.

Comparing 2025-11-10 vs 2025-08-11View on EDGAR →
FINANCIAL ANALYSIS

MNTN showed strong across-the-board growth with revenue increasing 52.7% to $203M and gross profit expanding 56.8% to $152.5M, indicating improving unit economics. The company achieved a critical milestone by swinging from a -$4.0M operating loss to $3.5M operating profit despite significantly increased R&D spending (+67.4%), while operating cash flow surged 53.1% to $26.9M. The balance sheet strengthened considerably with total liabilities declining 29.5% and stockholders' equity growing 11.6%, painting a picture of a rapidly scaling business that has reached operational profitability while maintaining strong cash generation and financial health.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+187.9%
-$4.0M$3.5M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

R&D Expense
P&L
+67.4%
$20.3M$34.1M

R&D investment increased 67.4% — signals commitment to future product development, though near-term margin impact.

Gross Profit
P&L
+56.8%
$97.2M$152.5M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Operating Cash Flow
Cash Flow
+53.1%
$17.6M$26.9M

Operating cash flow surged 53.1% — exceptional cash generation, highest quality earnings signal.

Revenue
P&L
+52.7%
$133.0M$203.0M

Strong top-line growth of 52.7% — accelerating demand or successful expansion into new markets.

Total Liabilities
Balance Sheet
-29.5%
$98.1M$69.1M

Liabilities reduced 29.5% — deleveraging improves balance sheet strength and financial flexibility.

Current Liabilities
Balance Sheet
-19.5%
$78.1M$62.9M

Current liabilities reduced — improved short-term financial position and working capital health.

Net Income
P&L
+13.6%
-$47.3M-$40.9M

Net income grew 13.6% — bottom-line growth signals improving overall business health.

Stockholders Equity
Balance Sheet
+11.6%
$238.9M$266.7M

Equity base grew 11.6% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2025-11-10
PRIOR — 2025-08-11
ADDED
Cautionary Note Regarding Forward-Looking Statements and Summary Risk Factors 3 Certain Definitions 4 PART I FINANCIAL INFORMATION Item 1.
Financial Statements (Unaudited) 5 Condensed Consolidated Balance Sheets 5 Condensed Consolidated Statements of Operations 6 Condensed Consolidated Statements of Stockholders Equity (Deficit ) 7 Condensed Consolidated Statements of Cash Flows 8 Notes to the Condensed Consolidated Financial Statements 9 Item 2.
Recently Issued Accounting Pronouncements Not Yet Adopted In December 2023, the Financial Accounting Standards Board (the "FASB") issued ASU No.
For public entities, this guidance will be effective on a prospective basis, with an option to apply it retrospectively, for annual periods beginning after December 15, 2024.
2023-09 are effective for annual periods beginning after December 15, 2025, with early adoption permitted.
+7 more — sign up free →
REMOVED
C autionary Note Regarding F orward -Looking Statements and Summary Risk Factors 3 C ertain Definitions 5 PART I FINANCIAL INFORMATION Item 1.
Financial Statements (Unaudited) 6 Condensed Consolidated Balance Sheets 6 Condensed Consolidated Statements of Operations 7 Condensed Consolidated Statements of Stockholders Equity ( Deficit ) 8 Condensed Consolidated Statements of Cash Flows 9 Notes to the Condensed Consolidated Financial Statements 11 Item 2.
Recently Issued Accounting Pronouncements Not Yet Adopted In December 2023, the FASB issued ASU No.
For public entities, this guidance will be effective on a prospective basis, with an option to apply it retrospectively, for annual periods beginning after December 15, 2024, with early adoption permitted.
2023-09 are effective for the Company for fiscal years beginning after December 15, 2025, with early adoption permitted.
+7 more — sign up free →
MORE OPPORTUNITY SIGNALS
IRIXHIGHIRIX demonstrated a dramatic operational turnaround with revenue surging 283% wh...
2026-04-02
CSAIHIGHCSAI underwent a dramatic financial transformation with revenue growing 271% to ...
2026-03-31
PLMKWHIGHPLMKW has entered into a definitive business combination agreement with Controll...
2026-03-31
LXEOHIGHLXEO achieved significant clinical milestones with positive interim data and reg...
2026-03-30
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →